Patents by Inventor Te Ning Chin

Te Ning Chin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9642922
    Abstract: Provided is an activatable probe that undergoes intramolecular cyclization and subsequent aggregation in apoptotic tumor cells upon peptidase-initiated, and most advantageously caspase-3, activation. These caspase-sensitive nano-aggregation probes (C-SNAFs) are generally biocompatible, possess NIR spectral properties or may serve as PET or MRI imaging agents, and have a mechanism of target-mediated nanostructure self-assembly amenable to in vivo use. The probes encompass biocompatible condensation chemistry products that comprise D-cysteine and 2-cyano-6-hydroxyquinoline (CHQ) moieties linked to an amino-luciferin scaffold, and which can be activated by a two-step reaction requiring caspase-3/7-mediated cleavage of an aspartate-glutamate-valine-aspartate (L-DEVD) capping peptide and the free intracellular thiol-mediated reduction of the disulfide bond.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: May 9, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jianghong Rao, Deju Ye, Adam Shuhendler, Frederick Te-Ning Chin, Jongho Jeon, Bin Shen
  • Publication number: 20150056137
    Abstract: Provided is an activatable probe that undergoes intramolecular cyclization and subsequent aggregation in apoptotic tumor cells upon peptidase-initiated, and most advantageously caspase-3, activation. These caspase-sensitive nano-aggregation probes (C-SNAFs) are generally biocompatible, possess NIR spectral properties or may serve as PET or MRI imaging agents, and have a mechanism of target-mediated nanostructure self-assembly amenable to in vivo use. The probes encompass biocompatible condensation chemistry products that comprise D-cysteine and 2-cyano-6-hydroxyquinoline (CHQ) moieties linked to an amino-luciferin scaffold, and which can be activated by a two-step reaction requiring caspase-3/7-mediated cleavage of an aspartate-glutamate-valine-aspartate (L-DEVD) capping peptide and the free intracellular thiol-mediated reduction of the disulfide bond.
    Type: Application
    Filed: August 20, 2014
    Publication date: February 26, 2015
    Inventors: Jianghong Rao, Deju Ye, Adam Shuhendler, Frederick Te-Ning Chin, Jongho Jeon, Bin Shen
  • Patent number: 4119882
    Abstract: An evacuated envelope includes front and back walls and a plurality of spaced, parallel support walls between and perpendicular thereto. The support walls form therebetween a plurality of channels. In each of the channels is at least one beam guide which confines electrons injected into the guide in a beam which travels along the beam guide but permits selective deflection of the beam out of the guide toward a phosphor screen on the inner surface of the front wall. A gun structure extends across one end of the channels for generating electrons and directing the electrons into the beam guides. The gun structure includes a thermionic emissive cathode extending across the ends of the channels and support members at spaced points along the cathode which support the cathode within the envelope but allow movement of the cathode with respect to the support members as a result of expansion or contraction of the cathode.
    Type: Grant
    Filed: February 22, 1977
    Date of Patent: October 10, 1978
    Assignee: RCA Corporation
    Inventor: Te Ning Chin